Results 261 to 270 of about 1,031,057 (311)

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

Burden of multiple myeloma in Asian countries from 1990 to 2021 and trend prediction for 2050: an analysis based on the Global Burden of Disease Study 2021. [PDF]

Front Med (Lausanne)
Hu C, Chen W, Zhang P, Shen T, Zhao Y.
europepmc   +1 more source

Global burden and projections of cervical cancer attributable to unsafe sex and smoking, 1990-2034. [PDF]

PLoS One
Hu J, Wang Y, Liu Y, Cai Z.
europepmc   +1 more source

The economic consequences of oral disorders at global, regional, and national levels. [PDF]

BMC Oral Health
Yang J, Zhang Q, Zheng D, Hou F.
europepmc   +1 more source

Global burden and cross-country inequalities in rabies from 1990 to 2021: a systemic analysis of the global burden of disease study 2021. [PDF]

BMC Infect Dis
Zuo QY, Lv WW, Qin Y, Yang J, Zhang YF, Yang GB, Zheng CJ, Zhou MG, Wang JC, Zhang SX.   +9 more
europepmc   +1 more source

Global, regional, and national burden of neonatal sepsis and other neonatal infections attributable to low birth weight: a systematic analysis of deaths, and DALYs with predictions to 2031. [PDF]

Front Pediatr
Jia X, Sun X, Wei K.
europepmc   +1 more source

Tiny lives, big failures: India's drug regulation crisis. [PDF]

Lancet Reg Health Southeast Asia
The Lancet Regional Health-Southeast Asia.
europepmc   +1 more source